X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (49) 49
index medicus (46) 46
female (34) 34
male (31) 31
oncology (31) 31
middle aged (30) 30
aged (27) 27
adult (23) 23
pharmacokinetics (22) 22
pharmacology & pharmacy (22) 22
cancer (20) 20
antineoplastic agents - pharmacokinetics (13) 13
research (13) 13
neoplasms - drug therapy (12) 12
aged, 80 and over (11) 11
chemotherapy (11) 11
abridged index medicus (10) 10
antineoplastic agents - adverse effects (10) 10
docetaxel (10) 10
drug interactions (10) 10
treatment outcome (10) 10
antineoplastic agents - administration & dosage (9) 9
hematology, oncology and palliative medicine (9) 9
antineoplastic agents - therapeutic use (8) 8
camptothecin - analogs & derivatives (8) 8
care and treatment (8) 8
pharmacology (8) 8
prospective studies (8) 8
antineoplastic agents (7) 7
camptothecin - pharmacokinetics (7) 7
dose-response relationship, drug (7) 7
drug administration schedule (7) 7
metabolism (7) 7
metastasis (7) 7
analysis (6) 6
animals (6) 6
antimitotic agents (6) 6
antineoplastic agents, phytogenic - pharmacokinetics (6) 6
camptothecin - adverse effects (6) 6
cell lung-cancer (6) 6
drug dosages (6) 6
efficacy (6) 6
expression (6) 6
health aspects (6) 6
pharmacogenetics (6) 6
studies (6) 6
tumors (6) 6
advanced solid tumors (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
area under curve (5) 5
article (5) 5
camptothecin - administration & dosage (5) 5
drug therapy (5) 5
exposure (5) 5
genetic aspects (5) 5
human plasma (5) 5
irinotecan (5) 5
neutropenia - chemically induced (5) 5
paclitaxel (5) 5
phase-i (5) 5
taxoids - administration & dosage (5) 5
taxoids - pharmacokinetics (5) 5
therapy (5) 5
toxicity (5) 5
active metabolite sn-38 (4) 4
administration, oral (4) 4
antineoplastic agents, phytogenic - administration & dosage (4) 4
association (4) 4
cancer research (4) 4
cisplatin (4) 4
clinical pharmacokinetics (4) 4
complications and side effects (4) 4
disease-free survival (4) 4
drug metabolism (4) 4
drug resistance, neoplasm (4) 4
gastrointestinal stromal tumors - drug therapy (4) 4
genetics & heredity (4) 4
genotype (4) 4
indoles - adverse effects (4) 4
kaplan-meier estimate (4) 4
metabolites (4) 4
mice, knockout (4) 4
neoplasms - metabolism (4) 4
neutropenia (4) 4
organic anion transporters - genetics (4) 4
performance liquid-chromatography (4) 4
pharmacology/toxicology (4) 4
phenotype (4) 4
physiological aspects (4) 4
pyrroles - adverse effects (4) 4
retrospective studies (4) 4
risk factors (4) 4
sunitinib (4) 4
survival (4) 4
tamoxifen (4) 4
usage (4) 4
young adult (4) 4
abiraterone (3) 3
adolescent (3) 3
anticancer agents (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer Supplements, ISSN 1359-6349, 2010, Volume 8, Issue 7, pp. 13 - 14
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 49, Issue 18, pp. 3821 - 3830
Journal Article
Oncogene, ISSN 0950-9232, 09/2013, Volume 32, Issue 36, pp. 4284 - 4293
Journal Article
European Urology, ISSN 0302-2838, 2015, Volume 68, Issue 4, pp. 621 - 629
Abstract Background In our exploratory studies, we associated single nucleotide polymorphisms (SNPs) in candidate genes with the efficacy and toxicities of... 
Urology | Metastatic renal cell carcinoma | Association analysis | Sunitinib | Pharmacogenetics | Biomarker | Single nucleotide polymorphism | VEGF | SU11248 | PHARMACOKINETICS | UROLOGY & NEPHROLOGY | HYPERTENSION | INHIBITOR | ASSOCIATION | SINGLE-NUCLEOTIDE POLYMORPHISMS | Haplotypes | Pyrroles - pharmacokinetics | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Netherlands | Cytochrome P-450 CYP3A - genetics | Time Factors | Antineoplastic Agents - adverse effects | Pyrroles - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Protein Kinase Inhibitors - pharmacokinetics | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Kidney Neoplasms - mortality | Disease Progression | Spain | Carcinoma, Renal Cell - mortality | Disease-Free Survival | Indoles - adverse effects | Cytochrome P-450 CYP3A - metabolism | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Renal Cell - secondary | ATP Binding Cassette Transporter, Sub-Family B - metabolism | Indoles - pharmacokinetics | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Ohio | Polymorphism, Single Nucleotide | Kidney Neoplasms - drug therapy | ATP Binding Cassette Transporter, Sub-Family B - genetics | Antimitotic agents | Pharmacy | Drugstores | Genetic aspects | Carcinoma, Renal cell | Metastasis | Single nucleotide polymorphisms | Antineoplastic agents | Chromosomes | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 51, Issue 17, pp. 2562 - 2569
Journal Article
ANNALS OF ONCOLOGY, ISSN 0923-7534, 10/2019, Volume 30, Issue 10, pp. 1591 - 1600
Androgen-deprivation therapy (ADT) has been the mainstay of treatment of metastatic prostate cancer since the first report of its hormonal dependence in the... 
PLUS PREDNISONE | MITOXANTRONE | OPEN-LABEL | metastatic castration-naive prostate cancer | DOCETAXEL | CHEMOTHERAPY | ANDROGEN-DEPRIVATION THERAPY | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | novel treatment options | predictive factors | INCREASED SURVIVAL | ABIRATERONE | ENZALUTAMIDE
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.